avapro and bms 248360

avapro has been researched along with bms 248360 in 4 studies

Research

Studies (4)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	4 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Barrish, JC; Baska, RA; Beyer, SM; Carlson, KE; Chong, S; Cornelius, LA; Dickinson, KE; Fadnis, L; Gu, Z; Kowala, MC; Kunst, BL; Macor, JE; Monshizadegan, H; Moreland, S; Morrison, RA; Murugesan, N; Panchal, B; Powell, JR; Tellew, JE; Valentine, MT; Yang, Y	1
Baska, RA; Beyer, SM; Carlson, KE; Cornelius, LA; Fadnis, L; Gu, Z; Kowala, MC; Kunst, BL; Macor, JE; Monshizadegan, H; Murugesan, N; Ryan, CS; Tellew, JE; Valentine, MT; Yang, Y	1
Baska, RA; Beyer, SM; Carlson, KE; Dickinson, KE; Ewing, WR; Fadnis, L; Gu, Z; Humphreys, WG; Kowala, MC; Lan, SJ; Macor, JE; Monshizadegan, H; Murugesan, N; Tellew, JE; Valentine, MT; Yang, Y; Zahler, R	1
Morphy, R; Rankovic, Z	1

Reviews

1 review(s) available for avapro and bms 248360

Article	Year
Designed multiple ligands. An emerging drug discovery paradigm. Journal of medicinal chemistry, 2005, Oct-20, Volume: 48, Issue:21 Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Anti-Allergic Agents; Anti-Inflammatory Agents, Non-Steroidal; Antidepressive Agents; Antihypertensive Agents; Antipsychotic Agents; Chemistry, Pharmaceutical; Dopamine D2 Receptor Antagonists; Drug Design; Humans; Ligands; Metabolic Diseases; Peroxisome Proliferator-Activated Receptors; Receptors, Histamine H1; Selective Serotonin Reuptake Inhibitors	2005

Article

Year

Designed multiple ligands. An emerging drug discovery paradigm.

Journal of medicinal chemistry, 2005, Oct-20, Volume: 48, Issue:21

Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Anti-Allergic Agents; Anti-Inflammatory Agents, Non-Steroidal; Antidepressive Agents; Antihypertensive Agents; Antipsychotic Agents; Chemistry, Pharmaceutical; Dopamine D2 Receptor Antagonists; Drug Design; Humans; Ligands; Metabolic Diseases; Peroxisome Proliferator-Activated Receptors; Receptors, Histamine H1; Selective Serotonin Reuptake Inhibitors

2005

Other Studies

3 other study(ies) available for avapro and bms 248360

Article	Year
Discovery of N-isoxazolyl biphenylsulfonamides as potent dual angiotensin II and endothelin A receptor antagonists. Journal of medicinal chemistry, 2002, Aug-29, Volume: 45, Issue:18 Topics: Angiotensin II; Angiotensin Receptor Antagonists; Animals; Antihypertensive Agents; Blood Pressure; CHO Cells; Cricetinae; Crystallography, X-Ray; Endothelin Receptor Antagonists; Isoxazoles; Molecular Structure; Radioligand Assay; Rats; Receptor, Angiotensin, Type 1; Receptor, Endothelin A; Structure-Activity Relationship; Sulfonamides	2002
Discovery of 4'-[(imidazol-1-yl)methyl]biphenyl-2-sulfonamides as dual endothelin/angiotensin II receptor antagonists. Bioorganic & medicinal chemistry letters, 2003, Mar-24, Volume: 13, Issue:6 Topics: Angiotensin Receptor Antagonists; Animals; Binding Sites; Biphenyl Compounds; Blood Pressure; Caco-2 Cells; Drug Design; Endothelin Receptor Antagonists; Humans; Imidazoles; Indicators and Reagents; Male; Rats; Rats, Sprague-Dawley; Receptor, Angiotensin, Type 1; Receptor, Endothelin A; Structure-Activity Relationship; Sulfonamides	2003
Dual angiotensin II and endothelin A receptor antagonists: synthesis of 2'-substituted N-3-isoxazolyl biphenylsulfonamides with improved potency and pharmacokinetics. Journal of medicinal chemistry, 2005, Jan-13, Volume: 48, Issue:1 Topics: Administration, Oral; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Animals; Antihypertensive Agents; Biological Availability; Biphenyl Compounds; Dogs; Endothelin A Receptor Antagonists; Humans; Hypertension; Irbesartan; Isoxazoles; Macaca fascicularis; Male; Rats; Rats, Inbred SHR; Receptor, Angiotensin, Type 1; Structure-Activity Relationship; Sulfonamides; Tetrazoles	2005